For smaller CV device companies seeking to launch or expand their clinical research programs, this paper reviews seven areas of focus for the safest and most expedient path to market.

This paper, from clinical research organization Novella Clinical, addresses key factors for smaller device companies to consider when bringing a cardiovascular product to market.